Monoclonal Antibody

Home
MONOCLONAL ANTIBODY:     Home   |   Staff & Contact   |  Services  |   Instruments  |  Core Resources  |  Reagents

Overview

The Monoclonal Antibody core develops new mouse monoclonal antibodies for investigators to use in basic and applied research. Major service categories include: immunization of mice, cell fusion, cell cloning, screening by ELISA and Western blot, monoclonal antibody production, purification and labeling, monoclonal antibody analyses such as antibody/antigen affinity measurements, epitope binning and identification of matched antibody pairs. Customer training on select self-service instruments is also offered.

Core News

Are BPA Alternatives Safer? New Research Takes a Look Are BPA Alternatives Safer? New Research Takes a Look
Are BPA Alternatives Safer? New Research Takes a Look
New research conducted at the University of Florida shows that a bisphenol A (BPA) alternative for making plastics, bisphenol S (BPS), could come with its own set of health risks. After past studies revealed the widely used BPA was contaminating food and water supplies, consumers quickly searched for alternatives. Market demand for BPA-free products led to the emergence of BPS as a commonly used bisphenol analog in plastic products. The UF | ICBR Proteomics and Mass Spectrometry (PM) core contri...
Read More
Are BPA Alternatives Safer? New Research Takes a Look
UPDATE: ICBR Continues to Provide Support to UF Community UPDATE: ICBR Continues to Provide Support to UF Community
UPDATE: ICBR Continues to Provide Support to UF Community
With the progression of recent events, there are a lot of questions about how it affects ICBR users. Please see below, important changes that could impact your experience at ICBR. These changes will be in place for the foreseeable future. Please refer back to this page for timely updates. As always, check the UF dedicated site for campus-wide information and initiatives. LATEST NEWS ICBR is now open, Monday through Friday, to support research on the University of Florida campus. Please be...
Read More
UPDATE: ICBR Continues to Provide Support to UF Community
CytoFLEX LX Available at UF | ICBR Cytometry CytoFLEX LX Available at UF | ICBR Cytometry
CytoFLEX LX Available at UF | ICBR Cytometry
The CytoFLEX Flow Cytometer, the first introduction to the CytoFLEX Platform, provides the performance you need in an easy to use system allowing you to focus on the science, not the instrumentation. Its superior sensitivity and resolution throughout all configurations give it the edge over other cytometry systems four times its size. All instruments in the platform utilize CytExpert for CytoFLEX Acquisition and Analysis Software. Reach out to UF | ICBR Cytometry to experience the CytoFLEX Platf...
Read More
CytoFLEX LX Available at UF | ICBR Cytometry
UF | ICBR: Shut Down for Academics for Black Lives UF | ICBR: Shut Down for Academics for Black Lives
UF | ICBR: Shut Down for Academics for Black Lives
UF | ICBR will be closed on the afternoon of Friday, June 19th, starting at noon and ending at 5pm, to allow employees time to reflect on our personal actions and continue to educate ourselves about racism. These efforts are in conjunction with those of the President of the University of Florida and Academics for Black Lives, an initiative intended for academic faculty and staff to examine the toll of racial trauma on Black people, combat racism and hate, and seek both accountability and colle...
Read More
UF | ICBR: Shut Down for Academics for Black Lives
Dr. Anna-Lisa Paul Appointed Director of UF ICBR Dr. Anna-Lisa Paul Appointed Director of UF ICBR
Dr. Anna-Lisa Paul Appointed Director of UF ICBR
The University of Florida Interdisciplinary Center for Biotechnology Research recently announced the appointment of its new director, Anna-Lisa Paul, Ph.D. Dr. Paul assumed the position effective March 20, 2020. For the past year, Dr. Paul has served as ICBR’s interim director. During that time, Dr. Paul spearheaded the center’s acquisition of state-of-the-art equipment and furthered ICBR’s collaborative relationship with UF Research departments. “The University of Florida Health Cancer Center h...
Read More
Dr. Anna-Lisa Paul Appointed Director of UF ICBR
ICBR Contributes to First Genomic Sequence of COVID-19 in New Orleans, LA ICBR Contributes to First Genomic Sequence of COVID-19 in New Orleans, LA
ICBR Contributes to First Genomic Sequence of COVID-19 in New Orleans, LA
While clinicians are working on the front lines to treat patients with COVID-19, researchers are working behind the scenes, investigating the viral life cycle and advancing new developments in therapeutics and vaccines. Critical to this research effort is determining the genetic code the virus uses for infection and propagation. UF | ICBR is doing its part to provide essential services to drive this research further; delivering support not only locally, but on a national scale. In a recent colla...
Read More
ICBR Contributes to First Genomic Sequence of COVID-19 in New Orleans, LA
UF Research Community Joins Hands to Donate Gloves, Masks and Other PPE UF Research Community Joins Hands to Donate Gloves, Masks and Other PPE
UF Research Community Joins Hands to Donate Gloves, Masks and Other PPE
The same personal protective equipment (PPE) that is used in research labs is also used in clinical settings. Currently, this equipment is incredibly valuable as health workers are on the front lines treating COVID-19. In keeping with the UF spirit of collaboration and innovation, researchers from across the University of Florida donated thousands of PPE to support local medical workers.The solicitation of the donation drive was orchestrated by UF|Research. The donated supplies, including gloves...
Read More
UF Research Community Joins Hands to Donate Gloves, Masks and Other PPE
New Publication from Bioinformatics’ Tongjun Gu New Publication from Bioinformatics’ Tongjun Gu
New Publication from Bioinformatics' Tongjun Gu
Bioinformatics assistant scientist Tongjun Gu Ph.D. has developed a two-step logistic regression model for association studies where known factors can serve as controls. The model is helpful for studies seeking to identify novel regulators in the RNA editing process where the dominant enzyme was found in the first step and served as a control in the second step. Advantages of the model: It considered the sequencing depth in the analysis. It can be validated in the first step by the association ...
Read More
New Publication from Bioinformatics’ Tongjun Gu

Staff

NameTitleTelephoneE-mailRoom
Angel SampsonMonoclonal Antibody Scientific Director(352) 273-8039angel.sampson@ufl.edu175 CGRC
Shadi BootorabiMonoclonal Antibody Senior Biological Scientist(352) 273-8041shb@ufl.edu171A CGRC
Mike MathieuMonoclonal Antibody Core Research Technician III(352) 273-8040Mikema91@ufl.edu171 CGRC